Holen Sie sich die Stockscreener-App
304.36
0.10%
0.1243
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$304.24
Offen:
$307.52
24-Stunden-Volumen:
387.52K
Relative Volume:
0.37
Marktkapitalisierung:
$29.88B
Einnahmen:
$3.17B
Nettoeinkommen (Verlust:
$642.63M
KGV:
28.27
EPS:
10.765
Netto-Cashflow:
$516.49M
1W Leistung:
+3.81%
1M Leistung:
+0.66%
6M Leistung:
-7.04%
1J Leistung:
-6.27%
1-Tages-Spanne:
$301.24
$307.86
1-Wochen-Bereich:
$293.34
$307.86
52-Wochen-Spanne:
$275.05
$414.15
Waters Corp Stock (WAT) Company Profile
Firmenname
Waters Corp
Sektor
Branche
Telefon
(508) 478-2000
Adresse
34 MAPLE ST, MILFORD, MA
Compare WAT vs TMO, DHR, IDXX, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WAT
Waters Corp
|
304.57 | 29.85B | 3.17B | 642.63M | 516.49M | 10.77 |
TMO
Thermo Fisher Scientific Inc
|
485.18 | 182.57B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
191.91 | 135.26B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
577.85 | 45.24B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
114.95 | 32.63B | 7.07B | 1.29B | 993.00M | 4.5355 |
Waters Corp Stock (WAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-10 | Fortgesetzt | Barclays | Overweight |
| 2026-02-10 | Fortgesetzt | Citigroup | Buy |
| 2026-02-10 | Fortgesetzt | Evercore ISI | In-line |
| 2026-01-06 | Eingeleitet | Guggenheim | Buy |
| 2026-01-05 | Eingeleitet | William Blair | Outperform |
| 2025-12-10 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-12-02 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2025-10-08 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-03-31 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-03-26 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-02-10 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2025-01-10 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-08 | Hochstufung | Jefferies | Hold → Buy |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-08-01 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2023-11-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-31 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2023-07-31 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-07-20 | Eingeleitet | UBS | Neutral |
| 2022-05-18 | Eingeleitet | Barclays | Overweight |
| 2022-05-17 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-04-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-07-06 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-01-07 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2020-12-17 | Hochstufung | Cleveland Research | Underperform → Buy |
| 2020-12-16 | Hochstufung | Citigroup | Sell → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Neutral |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-07-28 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2020-07-16 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2020-01-08 | Herabstufung | Needham | Hold → Underperform |
| 2020-01-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-01-07 | Eingeleitet | Citigroup | Sell |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-10-09 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2019-07-16 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-06-12 | Herabstufung | Cleveland Research | Neutral → Underperform |
| 2019-05-30 | Eingeleitet | Wolfe Research | Underperform |
| 2019-01-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-01-03 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-01-03 | Eingeleitet | Needham | Hold |
| 2018-12-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-11-30 | Herabstufung | Goldman | Neutral → Sell |
| 2018-10-11 | Hochstufung | Cleveland Research | Sell → Neutral |
Alle ansehen
Waters Corp Aktie (WAT) Neueste Nachrichten
Evercore ISI upgrades Waters stock rating on achievable targets - investing.com
Manufacturing Excellence Awards 2026: Waters Corp. - Worcester Business Journal
WAT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Waters Corporation (WAT) Stock Price, News, Quote & History - Yahoo! Finance Canada
Waters Corporation (WAT) stock price, news, quote and history - Yahoo Finance Singapore
Waters Corp (WAT) director gets deferred stock units grant - Stock Titan
Director Heather Knight granted deferred Waters (NYSE: WAT) stock units - Stock Titan
Waters Corp. stock outperforms competitors on strong trading day - marketwatch.com
Waters Corp (MIL:1WAT) Bonds - gurufocus.com
WAT Stock Price, Quote & Chart | WATERS CORP (NYSE:WAT) - ChartMill
Parkman Healthcare Partners LLC's Waters Corp(WAT) Holding History - GuruFocus
Goldman Sachs Reinstates Buy Rating on Waters (WAT) Stock - GuruFocus
Waters Corp. stock rises Tuesday, still underperforms market - marketwatch.com
Waters prices $3.5B senior notes offering - MSN
Waters Corp (WAT) Expands After BD Diagnostic Solutions Acquisition - Insider Monkey
Waters Corp (WAT) Trading Down 3.79% on Mar 30 - gurufocus.com
Waters Corp (LTS:0LTI) Bonds - GuruFocus
Waters Corp. stock underperforms Friday when compared to competitors - marketwatch.com
CONMED, Bruker, Waters Corporation, Avantor, and Bio-Techne Stocks Trade Down, What You Need To Know - Yahoo Finance
Vanguard disaggregates holdings; Waters Corp shows 0% stake (WAT) - Stock Titan
Waters (MIC:WAT-RM) NonCurrent Deferred Revenue : ₽0.00 Mil (As of Dec. 2025) - GuruFocus
Waters Corp Stock: Analytical Instruments Leader Faces Growth Challenges Amid Sector Tailwinds - AD HOC NEWS
Waters (MIL:1WAT) NonCurrent Deferred Revenue : €0 Mil (As of Dec. 2025) - GuruFocus
Becton Dickinson Biosciences & Diagnostics Unit to Merge With Waters Corp. in $17.5 Billion Deal - MSN
Waters Corp (WAT)'s Winning Formula: Financial Metrics and Compe - gurufocus.com
Waters (WAT) Prices $3.5 Billion Senior Notes Offering - Insider Monkey
Augusta SpinCo and Waters Corporation Announce $2 Billion Senior Notes Offering and Indenture Agreement – Details and Key Parties Involved - Minichart
Waters Corporation (WAT) Announces Successful $3.5 Billion Senio - GuruFocus
Waters Raises $3.5 Billion in Senior Notes to Refinance February Term Loan - TradingView
Waters (NYSE: WAT) subsidiary sells $3.5B in new senior notes - Stock Titan
Waters (WAT) 10K Form and Latest SEC Filings 2026 - MarketBeat
Swiss Life Asset Management Ltd Buys 3,789 Shares of Waters Corporation $WAT - marketbeat.com
ETF Watch: Is Waters Corporation stock forming a triangle pattern2026 Recap & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Waters Just Diluted Its Exposure to the Drug Manufacturing End Market by Buying BD Assets - Morningstar
Waters (NYSE: WAT) raises $3.5B via Augusta SpinCo senior notes offering - Stock Titan
Hudson Bay Capital Management LP Takes $19.49 Million Position in Waters Corporation $WAT - MarketBeat
Is Waters Corporation Stock Underperforming the Dow? - Yahoo Finance
Insider Buying: Wei Jiang Acquires Shares of Waters Corp (WAT) - gurufocus.com
Waters corp director Jiang Wei buys $144k in shares By Investing.com - Investing.com India
Waters (WAT) Director Acquires Additional Shares - GuruFocus
Waters corp director Jiang Wei buys $144k in shares - Investing.com
Graybill Wealth Management LTD. Makes New Investment in Waters Corporation $WAT - marketbeat.com
Blockbuster BD-Waters deal lifts med-tech M&A in early 2026 - BioWorld MedTech
SoFi shares drop as short seller Muddy Waters takes aim at company - Investing.com
London Co. of Virginia Has $166.65 Million Position in Waters Corporation $WAT - MarketBeat
Aquatic Capital Management LLC Makes New Investment in Waters Corporation $WAT - MarketBeat
Finanzdaten der Waters Corp-Aktie (WAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.36%
1.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):